Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors.
about
Avascular Necrosis of the Femoral Head: Are Any Genes Involved?Endothelial Response to Glucocorticoids in Inflammatory DiseasesRisk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.Venous thromboembolism (VTE) and glioblastoma.Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes.Thromboelastometry in veal calves to detect hemostatic variations caused by low doses of dexamethasone treatmentThrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor compositionRisk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.Postoperative glucocorticoid enhances recovery after endovascular aortic repair for chronic type B aortic dissection: a single-center experience.The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis ProfileTissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.Autoimmune diseases and venous thromboembolism: a review of the literature.The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia.Overview of venous thrombosis in inflammatory bowel disease.Retrospective comparison of thromboelastography results to postmortem evidence of thrombosis in critically ill dogs: 39 cases (2005-2010).Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.A venous thromboembolism risk assessment model for patients with Cushing's syndrome.Role of BCL2-associated athanogene 1 in differential sensitivity of human endothelial cells to glucocorticoids.In response to Laboratory assessment of sudden sensorineural hearing loss: A case-control study.The influence of corticosteroids on hemostasis in healthy subjects.Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease. A meta-analysis.Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.Thrombophlebitis of cephalic vein in the left forearm related to infliximab infusion.Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis.Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis.Anomalous coagulation factors in non-arteritic anterior ischemic optic neuropathy with central retinal vein occlusion: A case report.Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.Hydrocortisone in septic shock: all the questions answered?
P2860
Q26799377-F96A5D8E-5CC4-4AB3-BC92-0E1380F29787Q28073947-B75A17E3-0ECF-4F1C-BD99-D33D70C1A3E9Q30205757-1014CD5A-0474-4595-B188-EDDC8736ECBBQ33422929-96CD6C8A-0FE7-431D-94D8-5F1A7B290B4BQ33959230-C17D8E29-DC33-45D4-ADEA-C90CB330255DQ34636908-838B3C5E-4398-4181-BB3C-6B320E83E175Q35243446-BB4AF8A0-88E0-459D-9933-8CD000EF180CQ35770811-785FECE3-FBA6-4C0E-8068-56C7881A55ECQ35969813-F3869B89-9012-4049-B6BA-B17FC9D4B574Q36217509-6465452D-1C2E-4A14-B324-7B694020CA2FQ36453830-105741AE-3F6E-4D88-AB08-BA23B020DFECQ37631956-E61278D6-275B-4C96-80BA-1861E37BF7C6Q38039441-27A2F7C5-9E45-4146-A571-89C5D175F683Q38055656-CF0F9258-A9DD-4626-B810-6DCF09599372Q38077297-832FEF93-FC79-481C-B44D-80DFE5DF5C8DQ38315631-03F66D27-17E5-415C-AC21-13467A07950DQ40125387-E1611F3D-C6FF-4D87-89FA-97EAFF61532EQ40158592-533E8B59-3070-4F0C-91EC-773E057698AAQ40404975-CE3EC527-A59B-4E15-8941-7B78FEA522D5Q40795123-7D2C9666-DDA3-444E-B400-01520C11C309Q42356932-10FFE1B2-4F45-4316-A7AF-74770502FD7FQ48103891-7A7FF237-520A-474B-A8D3-2108EAD4E4E2Q48257684-C43F8D5F-7CBB-4421-B1C4-2FC9A0888458Q50003119-687F76C7-8889-463C-98C7-7DA5FF313CA5Q51529058-A91CE76C-E831-49D3-9BAD-7FC7AE09B0D6Q51532185-BA5867F4-160B-456B-A802-33E6E757E7E2Q53439990-64694C66-780A-422E-97F6-381FCD8ECE2EQ53664491-84C21313-7BFE-4C2E-8354-010AD6F9343FQ53669745-BF6FC9FB-B342-4D4C-A18F-6B2D2B18C0D8Q55083546-B7B34E85-FB10-4B54-A417-4A04DE64D71CQ55383390-4247C70B-00E6-4FE9-8DF1-26F896B1E4E6Q55710423-96761C8D-6699-4EC0-8F03-9FAFE4746BEB
P2860
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Systematic review on the effec ...... lant and fibrinolytic factors.
@en
Systematic review on the effec ...... lant and fibrinolytic factors.
@nl
type
label
Systematic review on the effec ...... lant and fibrinolytic factors.
@en
Systematic review on the effec ...... lant and fibrinolytic factors.
@nl
prefLabel
Systematic review on the effec ...... lant and fibrinolytic factors.
@en
Systematic review on the effec ...... lant and fibrinolytic factors.
@nl
P2093
P2860
P1476
Systematic review on the effec ...... ulant and fibrinolytic factors
@en
P2093
A Squizzato
B van Zaane
D P M Brandjes
H R Büller
V E A Gerdes
P2860
P304
P356
10.1111/J.1538-7836.2010.04034.X
P577
2010-11-01T00:00:00Z